Login

Atenetic 50/12.5mg & 100/25mg Film - coated Tablets *
Pharmacy Only: Prescription

  • Company:

    Gerard Laboratories

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Atenolol Chlortalidone

    *Additional information is available within the SPC or upon request to the company

Updated on 20 December 2018

File name

ateni ie-pl-clean-maht_1545319757.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 20 December 2018

File name

Ateni ie-spc-100mg25mg-clean-maht_1545319796.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 08 February 2016

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 29 January 2016

File name

PIL_9018_537.pdf

Reasons for updating

  • New PIL for new product

Updated on 29 January 2016

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
  • Addition of manufacturer

Updated on 30 October 2015

Reasons for updating

  • Change to side-effects

Updated on 29 May 2013

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
  • Change to improve clarity and readability
  • Change due to harmonisation of PIL

Updated on 16 November 2011

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information

Updated on 02 October 2006

Reasons for updating

  • Correction of spelling/typing errors

Updated on 23 August 2006

Reasons for updating

  • Change of active ingredient
  • Change to date of revision
  • Change to further information section
  • Change to storage instructions

Updated on 23 September 2004

Reasons for updating

  • New PIL for medicines.ie